$9.01
▼ $-0.09
(-0.99%)
Vol 135K
5
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$186.1M
ROE
-84.5%
Margin
-93.0%
D/E
102.91
Beta
1.23
52W
$4–$19
Wall Street Consensus
13 analysts · Apr 20263
Strong Buy
8
Buy
1
Hold
1
Sell
0
Strong Sell
84.6%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 50.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $-0.45 | $-0.46 | $-0.01 |
| Sep 2025 | $-0.51 | $-0.49 | +$0.02 |
| Jun 2025 | $-0.53 | $-0.57 | $-0.04 |
| Mar 2025 | $-0.58 | $-0.53 | +$0.05 |
Quarterly Revenue & Earnings
| Quarter | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|
| Revenue | $15.3M | $12.3M | $13.6M | $14.7M | $16.0M |
| Net Income | -$10.7M | -$13.8M | -$14.7M | -$12.9M | -$11.9M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -79.3% | -79.3% | -79.3% | -79.3% | -84.5% | -84.5% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -108.4% | -95.6% | -95.6% | -95.6% | -93.0% | -93.0% |
| Gross Margin | 84.3% | 83.5% | 83.5% | 83.5% | 84.5% | 84.5% |
| D/E Ratio | 85.26 | 85.26 | 85.26 | 85.26 | 102.91 | 102.91 |
| Current Ratio | 11.99 | 11.99 | 11.99 | 11.99 | 9.62 | 9.62 |
Key Ratios
ROA (TTM)
-42.1%
P/S (TTM)
3.32
P/B
4.3
EPS (TTM)
$-2.02
CF/Share
$-2.03
Rev Growth 3Y
+57.9%
52W High
$18.55
52W Low
$4.30
$4.30
52-Week Range
$18.55
Financial Health
Free Cash Flow
-$9.8M
Net Debt
-$25.2M
Cash
$75.7M
Total Debt
$50.5M
As of Dec 31, 2025
How does CVRX compare to Health Care peers?
Peer group: Micro-cap Health Care (All) · 241 companies
CVRX valuation vs Health Care peers
P/E ratio
—
▼
0%
below
peers
(30.7)
vs Peers
vs Industry
Undervalued
P/S ratio
3.3
▲
29%
above
peers
(2.6)
vs Peers
vs Industry
Pricier
P/B ratio
4.3
▲
56%
above
peers
(2.8)
vs Peers
vs Industry
Pricier
Div yield
—
▼
0%
below
peers
(0.7%)
vs Peers
vs Industry
Low yield
CVRX profitability vs Health Care peers
ROE
-84.5%
▼
119%
below
peers
(-38.5%)
vs Peers
vs Industry
Weak
Net margin
-93.0%
▼
276%
below
peers
(-24.7%)
vs Peers
vs Industry
Weak
Gross margin
84.5%
▲
60%
above
peers
(52.9%)
vs Peers
vs Industry
Top tier
ROA
-42.1%
▼
98%
below
peers
(-21.2%)
vs Peers
vs Industry
Weak
CVRX financial health vs Health Care peers
D/E ratio
102.9
▲
434%
above
peers
(19.3)
vs Peers
vs Industry
High debt
Current ratio
9.6
▲
345%
above
peers
(2.2)
vs Peers
vs Industry
Strong liquidity
Beta
1.2
▲
17%
above
peers
(1.1)
vs Peers
vs Industry
More volatile
CVRX fundamentals radar
CVRX
Peer median
Industry
CVRX profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
CVRX vs peers: key metrics
Insider Activity
NeutralBuys
0
Sells
0
HYKES KEVIN
Chief Executive Officer · Mar 02
7763 shs
VERRASTRO PAUL
Officer · Mar 02
1284 shs
OASHEIM JARED
Chief Financial Officer · Mar 02
1744 shs
JOHN ROBERT ALLEN
Officer · Mar 02
3964 shs
ADAMSON PHILIP B.
Officer · Mar 02
1262 shs
MORRISON GREGORY
Officer · Mar 02
34000 shs
HYKES KEVIN
Chief Executive Officer · Feb 27
159000 shs
BINKOWSKI BRENT
Chief Operating Officer · Feb 27
15000 shs
VERRASTRO PAUL
Officer · Feb 27
45000 shs
OASHEIM JARED
Chief Financial Officer · Feb 27
61000 shs
Last 90 days
Top Holders
Top 5: 35.12%Johnson & Johnson
15.30%
$35.9M
NEA Management Company, LLC
7.70%
$18.1M
Vanguard Group Inc
4.26%
$10.0M
Blackrock Inc.
4.03%
$9.5M
GSK plc
3.83%
$9.0M
As of Dec 31, 2025
Latest News
No related news yet